Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of
once-daily multiple-dose administration of odanacatib (MK0822).